0
0
Varanasi, June 10, 2025 — In a significant scientific breakthrough, researchers at Banaras Hindu University (BHU) have identified novel genetic markers that could revolutionize the early detection and treatment of gallbladder cancer, a disease notorious for its late diagnosis and poor prognosis, especially in India’s Gangetic belt.
Pioneering Research Using Advanced Technology
The research team, comprising Dr. Ruhi Dixit, Dr. Manoj Pandey, and Dr. Vijay Kumar Shukla, utilized state-of-the-art Clariom D Microarray technology to analyze gene expression profiles from three types of tissue samples: gallbladder cancer, cholelithiasis (gallstones), and healthy tissues. This marks the first time in India that such a comprehensive, three-way comparative transcriptomic analysis has been conducted.
Key Findings: Genetic Drivers and Early Markers
The study revealed 10 key genes that appear to drive cancer growth, most of which are involved in DNA repair mechanisms. Dysfunction in these genes is believed to promote the development and progression of gallbladder cancer. Notably, five genes were found to be common across all three groups, suggesting their potential as early markers for transformation before full-blown cancer develops.
In total, the researchers identified 3,898 genes with altered expression: 2,575 were upregulated and 1,323 downregulated in cancerous tissues. The main pathways implicated in carcinogenesis included mismatch repair, nucleotide excision repair, and homologous recombination.
A Step Forward in Cancer Diagnosis and Treatment
Gallbladder cancer is among the most common cancers in the Gangetic belt, yet it is often diagnosed at advanced stages, resulting in a five-year survival rate of just 10–20%. Despite more than two decades of research at BHU to uncover the disease’s causes, this latest study represents a significant leap forward.
The newly identified genetic markers could pave the way for improved diagnostic tools, more accurate prognosis, and personalized therapies, offering hope for better outcomes for patients in regions where gallbladder cancer is prevalent.
Looking Ahead
Building on previous transcriptomic studies, the BHU team’s findings clarify the genetic pathways involved in gallbladder carcinogenesis and highlight the promise of early intervention strategies. The research underscores the importance of genetic screening and targeted therapies in combating this deadly disease.
Disclaimer:
This article is based on preliminary research findings published by scholars at Banaras Hindu University and reported by the Economic Times Health. The results are promising but require further validation through clinical trials and peer-reviewed studies before they can be implemented in routine clinical practice. Readers should consult medical professionals for advice on diagnosis or treatment of gallbladder cancer.
